InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Wai Conrad, Chief Executive Officer. Officer active across 1 company, notably Clover Health Investments, CORP. /de. Cumulatively, 27 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €1.2m. Activity tracked since 14 June 2023. The latest transaction was disclosed on 15 July 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Wai Conrad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
24,215 shares@ US$4.670.0046% mcap2.3% of flowClass A Common StockSEC:0001801170-26-000178:0
220,426 shares@ US$3.990.040% mcap25.6% of flowClass A Common StockSEC:0001971702-26-000010:0
23,463 shares@ US$2.040.0033% mcap6.2% of flowClass A Common StockSEC:0001971702-26-000007:0
267,766 shares0Class A Common StockSEC:0001971702-26-000006:0
100,195 shares@ US$1.985.0% of flowClass A Common StockSEC:0001971702-26-000003:0
25,868 shares@ US$2.810.0051% mcap9.6% of flowClass A Common StockSEC:0001801170-26-000025:0
98,411 shares@ US$2.705.3% of flowClass A Common StockSEC:0001971702-25-000011:0
96,448 shares@ US$3.537.3% of flowClass A Common StockSEC:0001971702-25-000009:0
92,181 shares@ US$2.800.018% mcap34.1% of flowClass A Common StockSEC:0001971702-25-000006:0
98,412 shares@ US$3.066.9% of flowClass A Common StockSEC:0001801170-25-000227:0
27,930 shares@ US$2.892.2% of flowClass A Common StockSEC:0001801170-25-000186:0
118,600 shares@ US$3.2910.3% of flowClass A Common StockSEC:0001801170-25-000176:0
379,866 shares0Class A Common StockSEC:0001801170-25-000170:0
98,411 shares@ US$2.898.5% of flowClass A Common StockSEC:0001801170-25-000159:0
26,593 shares@ US$3.402.7% of flowClass A Common StockSEC:0001801170-25-000114:0
80,524 shares@ US$3.669.2% of flowClass A Common StockSEC:0001801170-25-000072:0
24,470 shares@ US$4.393.5% of flowClass A Common StockSEC:0001801170-25-000036:0
98,217 shares@ US$3.119.8% of flowClass A Common StockSEC:0001801170-24-000249:0
111,496 shares@ US$4.1214.3% of flowClass A Common StockSEC:0001801170-24-000228:0
726,114 shares0Class A Common StockSEC:0001801170-24-000212:0
189,934 shares0Class A Common StockSEC:0001801170-24-000192:0
69,148 shares@ US$1.092.4% of flowClass A Common StockSEC:0001801170-24-000128:0
74,396 shares@ US$0.731.7% of flowClass A Common StockSEC:0001801170-24-000071:0
96,086 shares@ US$1.003.0% of flowClass A Common StockSEC:0001801170-23-000119:0
440,000 shares0Class A Common StockSEC:0001801170-23-000096:0
25 of 27 declarations
About Wai Conrad
Wai Conrad is Directeur Général at Clover Health Investments, CORP. /de, where the stated role is CEO, Counterpart Health. Across 27 filings in total, the 27 most recent tracked filings cover the period from 2023-06-16 to 2026-07-16, with EUR 0 of buys and EUR 1188494 of sells, and the most frequent transaction nature is tax withholding.
